Anxiolytics and Sedative-Hypnotics: Nursing Pharmacology Study Guide

This note compares the major anxiolytic and sedative-hypnotic drug classes — benzodiazepines, barbiturates, Z-drugs, and buspirone — focusing on mechanisms, clinical uses, overdose management, and the nursing safety priorities that show up most often on the NCLEX.

Drug Classes at a Glance

Mechanisms of Action

• Benzodiazepines potentiate GABA by binding to specific receptor sites, increasing chloride influx and neuronal inhibition.
• Barbiturates directly activate GABA receptors and prolong chloride channel opening, producing greater CNS depression than benzodiazepines.
• Zolpidem selectively binds GABA-A receptors involved in sleep induction, with minimal muscle-relaxant effects.
• Buspirone is a partial agonist at serotonin 5-HT1A receptors with no GABA affinity.

Benzodiazepines

Indications

• Generalized anxiety disorder
• Insomnia (short-term)
• Preoperative sedation
• Alcohol withdrawal
• Seizures
• Muscle relaxation

Side Effects

• CNS depression — drowsiness, sedation, ataxia (especially in older adults)
• Anterograde amnesia — particularly with midazolam
• Respiratory depression — with IV use or when combined with other CNS depressants

Pharmacokinetics

• Onset varies: midazolam has rapid onset; diazepam has a long half-life with active metabolites.
• All are hepatically metabolized.

Overdose and Withdrawal

• Overdose signs: extreme drowsiness, confusion, ataxia, slurred speech, respiratory depression.
• Flumazenil is the antidote but may not fully reverse respiratory depression and can precipitate seizures in dependent patients.
• Supportive care, including airway management, is the priority.
• Withdrawal: abrupt discontinuation after long-term use causes panic, paranoia, agitation, insomnia, and delirium. A gradual taper is essential.

Nursing Safety Rules

• Use the smallest effective dose for the shortest duration (usually 2–4 weeks).
• Monitor older adults closely for ataxia, sedation, and fall risk.
• Avoid concurrent alcohol or other CNS depressants.
• Assess for substance abuse history.
• Do not stop abruptly — taper gradually.

Barbiturates

Indications

• Seizure disorders (phenobarbital)
• Anesthesia

Key Mechanism Point

Barbiturates directly activate GABA receptors even without GABA present, producing greater CNS depression than benzodiazepines and explaining their narrow therapeutic index.

Overdose

• No specific antidote.
• Treatment: activated charcoal within one hour; ventilator support for respiratory depression.
• Severe overdose causes coma, hypotension, and cardiac arrest.

Nursing Safety Rules

• Never use in patients with porphyria.
• Monitor respiratory rate and level of consciousness closely.
• Avoid abrupt discontinuation to prevent withdrawal seizures.
• Teach patients never to exceed the prescribed dose.

Z-Drugs (Non-Benzodiazepine Hypnotics)

• Drugs: Zolpidem (Ambien), Eszopiclone (Lunesta), Zaleplon (Sonata).
• Indicated only for short-term insomnia.
• Lower abuse potential than benzodiazepines, but tolerance can develop.

Nursing Safety Rules

• Take immediately before bedtime on an empty stomach for fastest onset.
• Ensure the patient has at least 7–8 hours available for sleep.
• Warn about next-day drowsiness; avoid driving until effects are known.
• Never combine with alcohol or other CNS depressants.
• Use cautiously in patients with a substance abuse history.
• Taper gradually when discontinuing.

Buspirone

Mechanism and Use

• Partial agonist at serotonin 5-HT1A receptors; no GABA affinity.
• Lacks sedative, muscle relaxant, and anticonvulsant properties; no cross-tolerance with benzodiazepines.
• FDA-approved for generalized anxiety disorder, especially when SSRIs are ineffective or not tolerated.
• Not effective for panic disorder, acute anxiety, or withdrawal syndromes.

Differences from Benzodiazepines

• Takes 2–4 weeks for therapeutic effect; not for acute relief.
• No sedation or cognitive impairment.
• No abuse potential or physical dependence.
• Does not potentiate alcohol effects.
• No withdrawal syndrome on discontinuation.

Side Effects

• Dizziness in over 10% of patients.
• Drowsiness, nausea, headache, nervousness, paresthesia.
• Rare: akathisia, serotonin syndrome.

Drug Interactions

• Avoid MAOIs (serotonin syndrome risk).
• CYP3A4 inhibitors (e.g., grapefruit juice) increase levels.
• Rifampin decreases efficacy.

Nursing Safety Rules

• Teach patients the full effect takes several weeks.
• When switching from a benzodiazepine, taper the benzodiazepine gradually while starting buspirone.
• Administer consistently with or without food.
• Monitor for serotonin syndrome.
• Dose adjustment is required in hepatic or renal impairment.

Class Comparison

Pregnancy Considerations

• Benzodiazepines should be avoided in the first trimester due to cleft palate risk.
• Use near delivery can cause neonatal withdrawal and floppy infant syndrome.
• Buspirone has limited human data; use only if benefits outweigh risks.
• Zolpidem safety data is limited.
• All anxiolytics should be used during pregnancy only when clearly necessary.

Common NCLEX Traps

• Forgetting that flumazenil reverses benzodiazepines but no antidote exists for barbiturates.
• Missing that buspirone takes weeks to work, with no sedation or abuse potential.
• Administering zolpidem without ensuring 7–8 hours of available sleep.
• Expecting buspirone to relieve acute anxiety.
• Stopping benzodiazepines abruptly — withdrawal can be mistaken for relapse.
• Missing fall risk in elderly patients.
• Forgetting that midazolam causes anterograde amnesia.
• Combining CNS depressants with alcohol → respiratory depression.
• Missing that grapefruit juice increases buspirone levels.

Key Takeaways

• Benzodiazepines potentiate GABA, are reversed by flumazenil, and must be tapered to prevent withdrawal.
• Barbiturates directly activate GABA, have a narrow therapeutic index, and have no antidote — supportive care is essential.
• Z-drugs treat short-term insomnia; ensure 7–8 hours of sleep is available and avoid alcohol.
• Buspirone is non-sedating, non-addictive, and takes 2–4 weeks to work — useless for acute anxiety.
• Avoid combining any of these agents with alcohol or other CNS depressants, and screen older adults for fall risk.